ZVRA
Zevra Therapeutics Inc.
11.10$
+3.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -159.9% | – | -472.0% | -429.5% | -491.0% | -134.9% | -40.3% | -13.9% | 18.1% | 16.2% | 17.0% | 42.9% | 24.5% | |
| 2.1% | – | 45.6% | 35.1% | 43.8% | 13.7% | 8.1% | 6.4% | 1.5% | 1.1% | 1.0% | 0.9% | 1.1% | |
| 47.9% | – | 61.9% | 59.2% | 166.1% | 33.4% | 15.3% | 9.5% | 10.6% | 12.6% | 8.6% | 7.5% | 9.6% | |
| 267.9% | – | -4.3% | -32.4% | -6.5% | 15.2% | -33.5% | -28.2% | -8.9% | -29.5% | 26.5% | -2.3% | -2.7% | |
| 5.9% | – | 2.1% | 0.0% | 0.0% | 0.0% | 0.5% | 0.8% | 2.1% | 0.1% | 0.1% | 0.5% | 0.6% | |
| -1,535.6% | – | 431.9% | -2.9% | -848.6% | -45.4% | 51.7% | 46.1% | -17.6% | 0.7% | 219.8% | 79.3% | 78.4% | |
| 0.0% | – | 100.6% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | |
| – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -165.9% | 0.0% | -44.2% | |
| 907.0% | – | 35.5% | 344.6% | 1,752.8% | 6.6% | 7.9% | 5.3% | 25.1% | 7.5% | -145.8% | 4.0% | -31.0% | |
| -792.0% | – | -5.8% | -80.7% | 400.0% | -168.2% | 17.4% | 40.1% | 25.8% | 23.3% | 91.6% | 125.4% | 71.7% | |
| -165.8% | – | -472.0% | -429.5% | -491.0% | -134.9% | -40.8% | -14.7% | 15.9% | 16.3% | 16.9% | 42.4% | 24.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.